Literature DB >> 28578254

Therapeutic drug monitoring of beta-lactam antibiotics - Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC-UV.

Nadine Pinder1, Thorsten Brenner2, Stefanie Swoboda3, Markus A Weigand2, Torsten Hoppe-Tichy3.   

Abstract

INTRODUCTION: Therapeutic drug monitoring (TDM) is a useful tool to optimize antibiotic therapy. Increasing interest in alternative dosing strategies of beta-lactam antibiotics, e.g. continuous or prolonged infusion, require a feasible analytical method for quantification of these antimicrobial agents. However, pre-analytical issues including sample handling and stability are to be considered to provide valuable analytical results.
METHODS: For the simultaneous determination of piperacillin, meropenem, ceftazidime and flucloxacillin, a high performance liquid chromatography (HPLC) method including protein precipitation was established utilizing ertapenem as internal standard. Long-term stability of stock solutions and plasma samples were monitored. Furthermore, whole blood stability of the analytes in heparinized blood tubes was investigated comparing storage under ambient conditions and 2-8°C.
RESULTS: A calibration range of 5-200μg/ml (piperacillin, ceftazidime, flucloxacillin) and 2-200μg/ml (meropenem) was linear with r2>0.999, precision and inaccuracy were <9% and <11%, respectively. The successfully validated HPLC assay was applied to clinical samples and stability investigations. At -80°C, plasma samples were stable for 9 months (piperacillin, meropenem) or 13 months (ceftazidime, flucloxacillin). Concentrations of the four beta-lactam antibiotics in whole blood tubes were found to remain within specifications for 8h when stored at 2-8°C but not at room temperature.
CONCLUSIONS: The presented method is a rapid and simple option for routine TDM of piperacillin, meropenem, ceftazidime and flucloxacillin. Whereas long-term storage of beta-lactam samples at -80°C is possible for at least 9 months, whole blood tubes are recommended to be kept refrigerated until analysis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Continuous infusion; High performance liquid chromatography; Plasma concentrations; Pre-analytical stability; S-Monovette Lithium-Heparin gel; Whole blood

Mesh:

Substances:

Year:  2017        PMID: 28578254     DOI: 10.1016/j.jpba.2017.05.037

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 2: Stability Evaluation.

Authors:  Ronilda D'Cunha; Thanh Bach; Beth Ann Young; Peizhi Li; Demet Nalbant; Jun Zhang; Patricia Winokur; Guohua An
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

Review 2.  Review of Chromatographic Methods Coupled with Modern Detection Techniques Applied in the Therapeutic Drugs Monitoring (TDM).

Authors:  Tomasz Tuzimski; Anna Petruczynik
Journal:  Molecules       Date:  2020-09-03       Impact factor: 4.411

3.  Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations.

Authors:  Nynke G L Jager; Reinier M van Hest; Jiao Xie; Gloria Wong; Marta Ulldemolins; Roger J M Brüggemann; Jeffrey Lipman; Jason A Roberts
Journal:  J Antimicrob Chemother       Date:  2020-09-01       Impact factor: 5.790

4.  Meropenem Stability in Human Plasma at -20 °C: Detailed Assessment of Degradation.

Authors:  Matthias Gijsen; Benjamin Filtjens; Pieter Annaert; Yeghig Armoudjian; Yves Debaveye; Joost Wauters; Peter Slaets; Isabel Spriet
Journal:  Antibiotics (Basel)       Date:  2021-04-16

5.  Demonstrating Feasibility of an Opportunistic Sampling Approach for Pharmacokinetic Studies of β-Lactam Antibiotics in Critically Ill Children.

Authors:  Sonya C Tang Girdwood; Peter H Tang; Mark E Murphy; Andrea R Chamberlain; Laura A Benken; Rhonda L Jones; Erin M Stoneman; Jennifer M Kaplan; Alexander A Vinks
Journal:  J Clin Pharmacol       Date:  2020-10-27       Impact factor: 3.126

6.  Dried Plasma Spot Based LC-MS/MS Method for Monitoring of Meropenem in the Blood of Treated Patients.

Authors:  Haiwei Cao; Yi Jiang; Shaomin Wang; Haihuan Cao; Yanyan Li; Jing Huang
Journal:  Molecules       Date:  2022-03-19       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.